![Multicenter phase-I/II study using a combination of gemcitabine and docetaxel in metastasized and unresectable, locally advanced pancreatic carcinoma]()
Multicenter phase-I/II study using a combination of gemcitabine and docetaxel in metastasized and unresectable, locally advanced pancreatic carcinomaK. Ridwelski; J. Fahlke; R. Kuhn; A. Hribaschek; E. Kettner; C. Greiner; A. Florschuetz; T. Manger; G. Wilhelm; H. Klein; S. Hahnfeld; H. Lippert; F. Meyer · 2006